Beyond Opioids: Personalizing Pain Treatment Through Genetics

​What ​if ​you ​could ​tell ​ahead ​of ​time ​who ​needed ​how ​much ​pain ​relief? ​What ​if ​you ​could ​avoid ​administering ​opioids ​to ​those ​with ​the ​highest ​risk ​of ​addiction, ​even ​if ​they ​didn't ​already ​know ​for ​themselves? What ​if ​you ​could ​help ​ease ​the ​pain ​of ​a ​patient ​in ​need ​and ​be ​sure ​that ​you've ​made ​the ​right ​call? Brian ​Meshkin ​of Proove ​Genomics shares his journey from personal tragedy to pioneering a scoring system that helps clinicians assess pain relief needs based on genetic profiles. Discover how this innovative approach aims to mitigate the opioid crisis by identifying patients at risk of addiction and personalizing pain treatment. Join us for an insightful discussion that blends science, compassion, and the urgent need for change in pain management.Find out more at https://proove.com/